Extended-release naltrexone feasibility in HIV clinics: A pilot study

被引：1

作者：

Korthuis, Todd ^{[3
]}

Lum, Paula J. ^{[5
]}

Vergara-Rodriguez, P. ^{[6
]}

Ahamad, Keith ^{[4
]}

Wood, Evan ^{[4
]}

Lindblad, R. ^{[1
]}

Mandler, Raul ^{[2
]}

Sorensen, James ^{[5
]}

Doan Ha ^{[3
]}

Oden, Neal ^{[1
]}

Kunkel, Lynn ^{[3
]}

McCarty, Dennis ^{[3
]}

机构：

[1] EMMES, Rockville, MD USA

[2] NIDA, Bethesda, MD 20892 USA

[3] OHSU, Portland, OR USA

[4] Univ British Columbia, Vancouver, BC, Canada

[5] UCSF, San Francisco, CA USA

[6] CORE Ctr, Chicago, IL USA

来源：

DRUG AND ALCOHOL DEPENDENCE | 2017年 / 171卷

关键词：

D O I：

10.1016/j.drugalcdep.2016.08.303

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

引用

页码：E108 / E108

页数：1

共 50 条

[21] A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and Probationers [J].

Coviello, Donna M. ;

Cornish, James W. ;

Lynch, Kevin G. ;

Boney, Tamara Y. ;

Clark, Cynthia A. ;

Lee, Joshua D. ;

Friedmann, Peter D. ;

Nunes, Edward V. ;

Kinlock, Timothy W. ;

Gordon, Michael S. ;

Schwartz, Robert P. ;

Nuwayser, Elie S. ;

O'Brien, Charles P. .

SUBSTANCE ABUSE, 2012, 33 (01) :48-59

[22] Injectable extended-release naltrexone for opioid dependence Reply [J].

Wolfe, Daniel ;

Carrieri, M. P. ;

Dasgupta, Nabarun ;

Bruce, Douglas ;

Wodak, Alex .

LANCET, 2011, 378 (9792) :666-666

[23] An update on naltrexone/bupropion extended-release in the treatment of obesity [J].

Saunders, Katherine H. ;

Igel, Leon I. ;

Aronne, Louis J. .

EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (16) :2235-2242

[24] Extended-release naltrexone for youth with opioid use disorder [J].

Mitchell, Shannon Gwin ;

Monico, Laura B. ;

Gryczynski, Jan ;

Fishman, Marc J. ;

O'Grady, Kevin E. ;

Schwartz, Robert P. .

JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 130

[25] Pharmacotherapy of opioid dependence with the extended-release injectable naltrexone [J].

Wang, A. L. ;

Elman, I. ;

Lowen, S. ;

Blady, S. J. ;

Lynch, K. G. ;

O'Brian, C. P. ;

Langleben, D. D. .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 :S696-S696

[26] Impact of Contingency Management on Adherence to Extended-Release Naltrexone [J].

Johnson, Shakevia ;

Hoefer, Michael .

AMERICAN JOURNAL ON ADDICTIONS, 2022, 31 (04) :366-367

[27] Extended-release naltrexone injectable suspension for treatment of alcohol dependence in urban primary care: A feasibility study, preliminary analysis [J].

Lee, J. D. ;

Grossman, E. ;

Dirocco, D. ;

Rotrosen, J. P. ;

Chuang, L. ;

Hanley, K. ;

Stevens, D. L. ;

Gourevitch, M. N. .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 :302-303

[28] Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study [J].

Anne Marciuch ;

Ida Halvorsen Brenna ;

Bente Weimand ;

Kristin Klemmetsby Solli ;

Lars Tanum ;

Bente K. Røstad ;

Bente Birkeland .

Addiction Science & Clinical Practice, 17

[29] Patients' experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study [J].

Marciuch, Anne ;

Brenna, Ida Halvorsen ;

Weimand, Bente ;

Solli, Kristin Klemmetsby ;

Tanum, Lars ;

Rostad, Bente K. ;

Birkeland, Bente .

ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)

[30] Hepatic Safety of Injectable Extended-Release Naltrexone in Patients With Chronic Hepatitis C and HIV Infection [J].

Mitchell, Mack C., Jr. ;

Memisoglu, Asli ;

Silverman, Bernard L. .

JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2012, 73 (06) :991-997

← 1 2 3 4 5 →